Manchester Phase I Clinical Research Unit
{"Image DocumentName": "Manchester Phase I Clinical Research Unit", "Image ImageDescription": "Clinical Trial Directive Implementation in 2004 negatively impacted most of UK based CPUs. Inadequate business development contributed to the sluggish business. High value and high risk studies combined with significant cancellations aggravated the situation. Imbalance between high science and low business acumen.", "Image XResolution": "37", "Image YResolution": "37", "Image ResolutionUnit": "Pixels/Centimeter", "Image Software": "SlidePlayer", "Image YCbCrPositioning": "Centered"}